Navigation Links
Scott & White Healthcare to participate in international trial investigating lung cancer treatment

Scott & White Healthcare in Round Rock, Texas is recruiting patients for a Phase III lung cancer trial aimed at preventing the disease's recurrence in previously treated patients. The trial will evaluate the potential of an immunotherapy called Antigen-Specific Cancer Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung Cancer (NSCLC).

The MAGRIT (MAGE-A3 as Adjuvant Non-Small Cell LunG Cancer Immunotherapy) study is expected to be one of the largest Phase III trials ever conducted for NSCLC. Scott & White Healthcare Round Rock is joining with 400 centers in more than 33 countries worldwide in this clinical research effort.

"The randomized, double-blind, placebo-controlled trial will enroll patients that demonstrate the MAGE-A3 biomarker and those who are assessed as stage IB, II, or IIIA resectable Non-Small Cell Lung Cancer," said Laura Beaty, M.D., principal investigator and hematology/oncologist at Scott & White Healthcare Round Rock. "The ASCI administration will be started in patients after surgery and standard chemotherapy, and in patients who only receive surgery as a standard of care as the primary endpoint of the trial is disease-free survival," she said.

ASCI is an investigational class of cancer immunotherapy agents aimed at educating the patient's immune system to identify cancer cells in a specific manner. This investigational cancer immunotherapy is developed using tumor-specific antigens. "If a patient's cancer is found to express certain proteins/antigens, then the treatment educates their immune system to fight their cancer cells," explained Dr. Beaty.

"This study is a global undertaking and we are looking for patients to consider enrolling," said Dr. Beaty. "To reach our enrolment target of 2,270 patients, we'll need to screen more than 13,000 patients worldwide."


Contact: Katherine Voss
Scott & White Healthcare

Page: 1

Related medicine news :

1. Scott & White Healthcare study aimed at T-cell lymphoma
2. Colt McCoy teams with Scott & White to build childrens hospital
3. Scottsdale Named One of US' Greenest Cities, Green Building Permits on the Rise
4. Scott Harter at Atrion International Receives EHS Gold Award From PPG Industries
5. Scott & White Healthcare physician to help develop global guidelines for Alzheimers
6. Scott & White Healthcare clinical trials target lymphoma, leukemia
7. Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages
8. New Varicose Vein Treatment Center Opens in Prescott, Arizona
9. Scott & White Healthcare researchers studying investigational agent that targets breast cancer
10. Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona
11. SUNZ Insurance Company Selects Scott Robertson as President
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra Medical, Inc. and Novus ... technology for soft tissue repair in the US via Insightra’s national direct sales ... mesh intended to support and reinforce soft tissue for 6-9 months before absorbing ...
(Date:11/30/2015)... ... 30, 2015 , ... SIMmersion’s ability to present dynamic scenarios ... of the future. To reach an audience of key visionaries and reformers in ... Chicago, organized by the American Medical Association. , AMA President Steven Stack, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... enterprise Time and Attendance/Workforce Management cloud-based solutions, announced today that it has ... competencies in the Application Development, demonstrating a “best-in-class” ability and commitment to ...
(Date:11/30/2015)... November 30, 2015 (PRWEB) , ... ... ... and Winscribe are pleased to announce their strategic partnership at the Radiological ... consultants, SpeechCheck, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
(Date:11/30/2015)... ... 30, 2015 , ... World Patent Marketing , a ... household invention that provides an economical and easy way of gaining customized curtains. ... at 2.6%," says Scott Cooper, CEO and Creative Director of World Patent Marketing. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
Breaking Medicine Technology: